Guggulsterone E&Z structure
|
Common Name | Guggulsterone E&Z | ||
---|---|---|---|---|
CAS Number | 95975-55-6 | Molecular Weight | 312.446 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 463.3±45.0 °C at 760 mmHg | |
Molecular Formula | C21H28O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 172.3±25.7 °C |
Use of Guggulsterone E&ZGuggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. |
Name | (Z)-Guggulsterone |
---|---|
Synonym | More Synonyms |
Description | Guggulsterone is a plant sterol derived from the gum resin of the tree Commiphora wightii. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases and JNK, inhibition of Akt[1]. Guggulsterone, a farnesoid X receptor (FXR) antagonist, decreases CDCA-induced FXR activation with IC50s of 17 and 15 μM for Z- and E-Guggulsterone, respectively[2]. |
---|---|
Related Catalog | |
Target |
JNK Akt Caspase |
In Vitro | Guggulsterone (0.5-20 μM; 24 hours) suppresses TREM-1, TLR4 and TNF-α expression as well as the phosphorylation of IκBα and NF-κB p65 by LPS[2]. Western Blot Analysis[1] Cell Line: RAW 264.7 murine macrophage cells Concentration: 0.5, 5, 10, 20 μM Incubation Time: 24 hours Result: Suppressed TREM-1, TLR4, and TNF-α expression as well as the phosphorylation of IκBα and NF-κB p65 by LPS. |
In Vivo | Guggulsterone (orally; 100 mg/kg once per day for 8 days) significantly improved the survival rates of wild-type mice with TNBS-induced colitis[2]. Animal Model: Wild-type mice with TNBS-induced colitis[2] Dosage: 100 mg/kg Administration: Orally; once per day; for 8 days Result: Improved the survival rates of wild-type mice with TNBS-induced colitis. |
References |
[1]. Shishodia S, et al. Guggulsterone for Chemoprevention of Cancer. Curr Pharm Des. 2016;22(3):294-306. |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 463.3±45.0 °C at 760 mmHg |
Molecular Formula | C21H28O2 |
Molecular Weight | 312.446 |
Flash Point | 172.3±25.7 °C |
Exact Mass | 312.208923 |
PSA | 34.14000 |
LogP | 3.65 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.557 |
Storage condition | 2-8°C |
Water Solubility | DMSO: 5 mg/mL |
Z-Guggulsterone |
Cis-Guggulsterone |
Neuropeptide W-23 (human) |
CIS GUGGULSTERONE |
GUGGULSTERONE Z(P) |
GUGGULSTERONE, (Z)- |
E-guggulsterone |
Z-Gugglesterone |
GUGGULSTERONE Z |
(4,17(20)t)-Pregnadien-3,16-dion |
Guggulsterone Z (25 mg) |
Guggulsterone |
GUGGULESTERONE Z |
Pregna-4,17(20)-diene-3,16-dione, (17Z)- |
MFCD01310757 |
(17Z)-Pregna-4,17-diene-3,16-dione |
4,17(20)-Z-pregnadiene-3,16-dione |
GUGGULSTERONE (Z FORM) |
GUGULSTERONE |
UNII:6CST3U34GN |
Pregna-4,17-diene-3,16-dione, (17Z)- |
Z-Guggulsteron |